How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

28,320 results for

Topical Corticosteroid

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids

Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Continuous (...) Glucose Monitoring of Late Preterm Birth After Corticosteroids The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03738293 Recruitment Status : Not yet recruiting First Posted : November 12, 2018 Last Update Posted : November

2018 Clinical Trials

142. Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)

allocation until the end of their involvement in the trial and after the completion of the trial Primary Purpose: Treatment Official Title: Effect of Corticosteroids On MyocardiaL Injury Among Patients Hospitalized for Community-AcquirEd PneUMonia - COLOSSEUM TRIAL Estimated Study Start Date : January 10, 2019 Estimated Primary Completion Date : May 16, 2020 Estimated Study Completion Date : September 1, 2022 Resource links provided by the National Library of Medicine related topics: available for: Arms (...) : corticosteroids Additional relevant MeSH terms: Layout table for MeSH terms Pneumonia Lung Diseases Respiratory Tract Diseases Respiratory Tract Infections Pharmaceutical Solutions Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone phosphate Anti-Inflammatory Agents Antiemetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Gastrointestinal Agents Glucocorticoids Hormones

2018 Clinical Trials

143. Treatment of Hypertrophic Scars Using Laser-Assisted Corticosteroid Versus Laser-Assisted 5-Fluorouracil Delivery. (Abstract)

topical triamcinolone acetonide (20 mg/mL) or topical 5-fluorouracil (50 mg/mL).Three sessions of laser-assisted triamcinolone acetonide and 5-fluorouracil delivery both produced reductions in overall scar area. When compared with one another, there were no statistically significant differences in area reduction between the 2 modalities (p = .603). However, scars treated with 5-fluorouracil were not associated with side effects seen with corticosteroid therapy, such as dermal atrophy or telangiectasia (...) Treatment of Hypertrophic Scars Using Laser-Assisted Corticosteroid Versus Laser-Assisted 5-Fluorouracil Delivery. As the mortality of individuals suffering severe cutaneous injuries decreases, there is an increased need to improve the methods by which physicians treat the resultant scars. Fractional lasers, which create zones of ablation at variable depths, provide a powerful tool in the management of scar complications and deformities. After disruption of the normal skin barrier, these zones

2018 Dermatologic Surgery

144. Efficacy of Dehydrated Cell and Protein Concentrate Versus Corticosteroid

Efficacy of Dehydrated Cell and Protein Concentrate Versus Corticosteroid Efficacy of Dehydrated Cell and Protein Concentrate Versus Corticosteroid - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy (...) of Dehydrated Cell and Protein Concentrate Versus Corticosteroid The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03710005 Recruitment Status : Recruiting First Posted : October 17, 2018 Last Update Posted : November 9, 2018 See

2018 Clinical Trials

145. Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. Full Text available with Trip Pro

drop use resulted in fewer dose reductions (5% vs. 15%) and none discontinued due to ocular AEs.Preclinical modeling was predictive of the corneal-related symptoms seen in some patients dosed with mirvetuximab soravtansine. Primary prophylactic use of topical corticosteroid eye drops resulted in a trend toward symptomatic improvement and a reduction in ocular AE-related dose modifications in patients treated with mirvetuximab soravtansine.©2018 American Association for Cancer Research. (...) Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. Reversible, low-grade ocular adverse events (AE) are associated with administration of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeted antibody-drug conjugate undergoing phase III clinical evaluation in platinum-resistant ovarian cancer. This study investigated the underlying mechanisms of ocular toxicity

2018 Clinical Cancer Research

146. Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children

the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children Actual Study Start Date : October 22, 2016 Estimated Primary Completion Date : December 31, 2019 Estimated Study Completion Date : December 31, 2019 Resource links provided by the National Library of Medicine related topics: available for: Groups and Cohorts Go to Group/Cohort Intervention/treatment NTUH National Taiwan University Hospital, all participants receive Duasma (budesonide, 200mcg/puff) Drug: Budesonide/Cisclesonide One arm (...) Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2018 Clinical Trials

147. Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects Actual Study Start Date : March 20, 2018 Estimated Primary Completion Date : August 2019 Estimated Study Completion Date : August 2019 Resource links provided by the National Library of Medicine related topics: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental: Itacitinib + corticosteroids Itacitinib administered in combination (...) Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save

2018 Clinical Trials

148. Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger

Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03583151 Recruitment Status : Enrolling by invitation First Posted : July 11, 2018 Last Update Posted : July 11, 2018 Sponsor: J&M Shuler Collaborator: Vivex Biomedical Information

2018 Clinical Trials

149. GRAVITAS-309: Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Library of Medicine related topics: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental: Itacitinib + corticosteroids Itacitinib administered in combination with corticosteroids. Drug: Itacitinib In Part 1 participants will receive itacitinib administered orally once daily at the protocol-defined dose according to cohort enrollment. In Part 2, participants will receive the recommended dose from Part 1. Other Name: INCB039110 Drug: Methylprednisolone Administered in Parts 1 (...) : Yes Studies a U.S. FDA-regulated Device Product: No Keywords provided by Incyte Corporation: Graft-versus-host-disease itacitinib Janus kinase inhibitor corticosteroids Additional relevant MeSH terms: Layout table for MeSH terms Graft vs Host Disease Immune System Diseases Prednisone Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone phosphate Anti-Inflammatory Agents Glucocorticoids Hormones

2018 Clinical Trials

150. Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

With Severe Eosinophilic Asthma on High Dose Inhaled Corticosteroid Plus Long-acting β2 Agonist and Chronic Oral Corticosteroid Therapy Actual Study Start Date : August 1, 2018 Estimated Primary Completion Date : October 30, 2020 Estimated Study Completion Date : October 30, 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Benralizumab Benralizumab subcutaneous injection Biological (...) Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2018 Clinical Trials

151. Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy

: Double (Participant, Investigator) Primary Purpose: Treatment Official Title: Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy Actual Study Start Date : September 11, 2018 Estimated Primary Completion Date : January 1, 2020 Estimated Study Completion Date : January 1, 2020 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Corticoids Drug: Corticoids Patients will receive (...) is to evaluate the efficacy of oral corticosteroid therapy in remobilization of vocal cords at seven days in patients with unilateral recurrent paralysis after thyroidectomy. Condition or disease Intervention/treatment Phase Recurrent Paralysis of Vocal Cords Drug: Corticoids Other: Placebo Phase 3 Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 156 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking

2018 Clinical Trials

152. COrticosteroids in acUte uRticAria in emerGency dEpartment

: Treatment Official Title: COrticosteroids in acUte uRticAria in emerGency dEpartment Estimated Study Start Date : December 1, 2018 Estimated Primary Completion Date : November 15, 2020 Estimated Study Completion Date : January 15, 2021 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Antihistamines + placebo of cortancyl - In emergency department : Levocetirizine 5 mg orally. Renewable once (...) COrticosteroids in acUte uRticAria in emerGency dEpartment COrticosteroids in acUte uRticAria in emerGency dEpartment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. COrticosteroids in acUte uRticAria

2018 Clinical Trials

153. Systemic Corticosteroids Avoidance Study in Severe Asthma Patients

: Treatment Official Title: A 52-week, Multicenter, Randomized, Double-blind, Double-dummy, Parallel-group, Placebo-controlled Study of Fevipiprant Once Daily Plus Standard-of-care (SoC) for Reduction of Systemic Corticosteroids (Oral and Parenteral) Use in Patients With Severe Asthma Estimated Study Start Date : December 7, 2018 Estimated Primary Completion Date : May 27, 2021 Estimated Study Completion Date : May 27, 2021 Resource links provided by the National Library of Medicine related topics: Arms (...) Systemic Corticosteroids Avoidance Study in Severe Asthma Patients Systemic Corticosteroids Avoidance Study in Severe Asthma Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Systemic Corticosteroids

2018 Clinical Trials

154. Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma

Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Inflammation (...) Following Mepolizumab and Oral Corticosteroids in Asthma (MAPLE) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03610685 Recruitment Status : Recruiting First Posted : August 1, 2018 Last Update Posted : December 10, 2018

2018 Clinical Trials

155. A Prospective Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves Versus Facet Joint Injection of Corticosteroid for the Treatment of Lumbar Facet Syndrome

: None (Open Label) Primary Purpose: Treatment Official Title: A Prospective Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves Versus Facet Joint Injection of Corticosteroid for the Treatment of Lumbar Facet Syndrome Actual Study Start Date : October 1, 2018 Estimated Primary Completion Date : August 1, 2023 Estimated Study Completion Date : December 1, 2024 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention (...) A Prospective Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves Versus Facet Joint Injection of Corticosteroid for the Treatment of Lumbar Facet Syndrome A Prospective Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves Versus Facet Joint Injection of Corticosteroid for the Treatment of Lumbar Facet Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search

2018 Clinical Trials

156. Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China

, 2017 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Outcome Measures Go to Primary Outcome Measures : The length of hospital stay(days) [ Time Frame: day 1 to up to 30 days (Hospital discharge) ] Evaluate the clinical outcome among 3 treatment groups (1=Nebulised Budesonide (BUD), 2=Nebulised BUD+ Systemic corticosteroids (SCS), 3=SCS) The rate of mortality [ Time Frame: day 1 to up to 30 days (Hospital discharge) ] Evaluate the clinical outcome (...) Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2018 Clinical Trials

157. Pain Outcomes Following Intralesional Corticosteroid Injections

University Medical Center Information provided by (Responsible Party): Brian Drolet, Vanderbilt University Medical Center Study Details Study Description Go to Brief Summary: Corticosteroid therapy, including intralesional and topical applications, has many indications within the fields of Dermatology, Plastic Surgery, and Orthopedics. However, these injections can be quite painful, which leads many patients to discontinue treatment. Often, the injection involves a mixture of local anesthetic (...) of Medicine related topics: related topics: available for: resources: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Corticosteroid with lidocaine This arm will include an injection mixture of corticosteroid and lidocaine Drug: Corticosteroid with lidocaine Intralesional corticosteroid injection Experimental: Corticosteroid with normal saline This arm will include a mixture of corticosteroid and normal saline. The purpose of normal saline is to keep the volume and concentration

2018 Clinical Trials

158. Endophthalmitis After Intravitreal Injection of Antiangiogenic Agents or Corticosteroids, a Cohort Study of the French Population of Patients Who Received Injections Over 9 Years

Endophthalmitis After Intravitreal Injection of Antiangiogenic Agents or Corticosteroids, a Cohort Study of the French Population of Patients Who Received Injections Over 9 Years Endophthalmitis After Intravitreal Injection of Antiangiogenic Agents or Corticosteroids, a Cohort Study of the French Population of Patients Who Received Injections Over 9 Years - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results (...) information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Endophthalmitis After Intravitreal Injection of Antiangiogenic Agents or Corticosteroids, a Cohort Study of the French Population of Patients Who Received Injections Over 9 Years (ENIVAC) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators

2018 Clinical Trials

159. Effect of Antenatal Corticosteroids on Neonatal Morbidity.

Masking: Triple (Participant, Care Provider, Investigator) Masking Description: double blind Primary Purpose: Prevention Official Title: Effect of Antenatal Corticosteroids on Neonatal Morbidity. Actual Study Start Date : December 1, 2017 Estimated Primary Completion Date : May 31, 2019 Estimated Study Completion Date : July 31, 2019 Resource links provided by the National Library of Medicine related topics: available for: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental (...) Effect of Antenatal Corticosteroids on Neonatal Morbidity. Effect of Antenatal Corticosteroids on Neonatal Morbidity. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effect of Antenatal Corticosteroids

2018 Clinical Trials

160. Antenatal Corticosteroid in Elective Cesarean Section

: Role of Antenatal Corticosteroid Use in Elective Term Cesarean Section Estimated Study Start Date : February 2018 Estimated Primary Completion Date : February 2019 Estimated Study Completion Date : April 2019 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Dexamethasone Dexamethasone 6mg, IM, 48 hours before cesarean section Drug: Dexamethasone Dexamethasone 6mg, IM, 48 hours before (...) Antenatal Corticosteroid in Elective Cesarean Section Antenatal Corticosteroid in Elective Cesarean Section - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Antenatal Corticosteroid in Elective Cesarean

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>